Norden Group’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Norden Group's BMY Position: Q2 2026 in Review
Norden Group increased its Bristol-Myers Squibb (BMY) stake by 11% in Q2 2026, buying an estimated $1.32M and bringing the position to 223,889 shares worth $12.9M. The position accounts for 1.06% of the portfolio, ranked #15.
Norden Group first reported a position in BMY in Q3 2023 and has held it in 12 quarters since. 2,517 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Norden Group held 223,889 shares of Bristol-Myers Squibb worth $12.9M as of Q2 2026.
- Norden Group bought 23,065 Bristol-Myers Squibb shares in Q2 2026, an estimated $1.32M.
- Bristol-Myers Squibb made up 1.06% of Norden Group's portfolio in Q2 2026, its #15 holding.
- Norden Group first reported a position in Bristol-Myers Squibb in Q3 2023 and has held it in 12 quarters since.
- 2,517 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Norden Group's 13F filing for Q2 2026, filed 29 Jul 2026.